Dosimetry Analysis of 177Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial

By afschroeder • April 3, 2026

Ells Z, Meyer C, Kimura K, Wilhalme H, Cao M, Ludwig VB, Unterrainer LM, Sennung D, Nabong R, Felix C, Valle LF, Daley A, Czernin J, Dahlbom M, Kishan AU, Calais J. Dosimetry Analysis of ¹⁷⁷Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial. J Nucl Med. 2026 Apr 2:jnumed.125.271467. doi: 10.2967/jnumed.125.271467. Epub ahead of print. PMID: 41927282.

Tags: 177Lu, 177Lu-PSMA-I&T, Cardiology/Epi, DOM STAT, dosimetry, General Internal Medicine, oligorecurrent, prostate cancer, PSMA, Publications, SBRT, theranostics

Cardiovascular Risk Stratification and Surveillance in Cardio-Oncology: Mechanistic Foundations and Future Directions

Gajjar A, Shah SAY, Gajjar A, Allam KC, Beech B, Pfaff A, Brochu C, Dani S, Ganatra S. Cardiovascular Risk Stratification and Surveillance in Cardio-Oncology:[...]

Racial and Ethnic Differences in Dietary Intake and Metabolic Profiles Among Adults with Heart Failure, Type 2 Diabetes, and Overweight or Obesity: A Secondary Analysis of the Pro-HEART Trial

Evangelista LS, Nguyen AP, Kawi J, Meraz R, Wierenga KL, Angosta AD, Hamilton MA, Fonarow GC. Racial and Ethnic Differences in Dietary Intake and Metabolic[...]

Beyond Statins: Role of Inflammation and Risk of Cardiovascular Events in HIV

Hsue PY, Garshick MS, Wilkinson MJ, Kalra DK. Beyond Statins: Role of Inflammation and Risk of Cardiovascular Events in HIV. JACC Adv. 2026 Aug;5(8):103064. doi:[...]